Phase Genomics Wins $1.5M for Proximity Ligation-Based AMR Tracking
Seattle-based startup Phase Genomics announced Tuesday it has received a two-year, $1.5 million grant from the National Institutes of Health to support the development of a rapid antimicrobial resistance tracking kit based on the firm’s proprietary high-throughput chromatin conformation, or Hi-C, proximity ligation technology.
The Phase II Small Business Innovation Research funds were awarded by the National Institute of Allergy and Infectious Diseases. The funding will support the development of a low-cost platform to detect antimicrobial resistance elements in microbial communities without the need for bacterial culture.
Display your AMR technology / product:
Global AMR Technologies Database
- Preventive – Diagnostic – Antimicrobial technologies
- Academia – Research Institutes – Start ups – SMEs – Multinationals
- Early research <-> near market (max 5)
- Global reach for funding / co-development / licensing
- No costs (until year end 2019)
Festive Launch Database 19 Nov Symposium Dinner ‘Emerging Antimicrobials and Diagnostics in AMR 2019‘
Click to join the Symposium Dinner (to join the Symposium separate registration obligatory)